Hyperion Defi (HYPD) Net Cash Flow (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Net Cash Flow of $937455.0 for Q1 2026, down 48.31% year-over-year from $1.8 million in Q1 2025, and up 152.3% quarter-over-quarter from -$1.8 million in Q4 2025.
Hyperion Defi (HYPD) Net Cash Flow (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Net Cash Flow for 10 consecutive years, with $937455.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 48.31% year-over-year to $937455.0; the TTM figure through Mar 2026 stood at $49.0 million (up 1318.08% YoY), while the FY2025 annual figure was $4.3 million, up 134.01% from the prior year.
- Net Cash Flow improved to $937455.0 in Q1 2026 per HYPD's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $49.1 million in Q2 2025 and bottomed at -$6.9 million in Q1 2024.
- Historically, Net Cash Flow has averaged $1.5 million across 5 years, with a median of -$1.8 million in 2025.
- Annual changes were most pronounced in 2022 — Net Cash Flow plunged 512.04% — and 2025, when it jumped 965.52%.
- Hyperion Defi's Net Cash Flow stood at -$2.4 million in 2022, then tumbled by 143.35% to -$5.9 million in 2023, then grew by 13.8% to -$5.0 million in 2024, then jumped by 64.48% to -$1.8 million in 2025, then soared by 152.3% to $937455.0 in 2026.
- Business Quant data shows HYPD's Net Cash Flow at $937455.0 in Q1 2026, -$1.8 million in Q4 2025, and $703505.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.39 Mn |
| Jun 30, 2026 | 2.39 Mn |
| Mar 31, 2026 | 937,455.00 |
| Mar 31, 2026 | 937,455.00 |
| Dec 31, 2025 | -1.79 Mn |
| Dec 31, 2025 | -1.79 Mn |
| Sep 30, 2025 | 703,505.00 |
| Sep 30, 2025 | 703,505.00 |
| Jun 30, 2025 | 49.12 Mn |
| Jun 30, 2025 | 49.12 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Mar 31, 2025 | 1.81 Mn |
| Dec 31, 2024 | -5.05 Mn |
| Dec 31, 2024 | -5.05 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Sep 30, 2024 | 4.89 Mn |
| Jun 30, 2024 | -5.68 Mn |
| Jun 30, 2024 | -5.68 Mn |
| Mar 31, 2024 | -6.87 Mn |
| Mar 31, 2024 | -6.87 Mn |